|Videos|March 12, 2021
Recent Advances in the Treatment of Hereditary ATTR Amyloidosis (hATTR)
Author(s)John L. Berk, MD
P. James B. Dyck, MD
P. James B. Dyck, MD
Key insight into treating ATTR Amyloidosis, including the use of new therapeutic options to provide a practical perspective on how recent data may apply to your clinical practice.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Pathophysiology of Myasthenia Gravis
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
International Committee Publishes 2024 Revisions to McDonald Diagnostic Criteria for Multiple Sclerosis
2
New Study Finds Link Between Gut Hormone GLP-1 and NMOSD Symptoms, Paving Way for Targeted Treatments
3
RELIEV-CM Pilot Study Data Further Supports ShiraTronics’ Neuromodulation Device to Treat Chronic Migraine
4
SKY-0515 Demonstrates Dose-Dependent Reductions in Mutant Huntingtin Protein in Phase 1 Update
5